Online inquiry

IVTScrip™ pT7-VEE-mRNA-FLuc Vector   (CAT#: GTVCR-WQ003MR)

The vector is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies, protein expression, and biological imaging. The system was driven by the T7 promoter to efficiently generate Fluc mRNA through T7 RNA polymerase and nucleotides under appropriate reaction conditions. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
5' UTR Kozak seq
Resistance Ampicillin
Species Firefly
Applications Reporter gene; IVT; Self-amplifying mRNA (SAM) research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-FLuc Vector (GTVCR-WQ003MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ485MR IVTScrip™ pSP6-VEE-mRNA-Anti-ICOS, AMG-570 Vector Vector AMG-570
GTVCR-WQ406MR IVTScrip™ pT7-VEE-mRNA-Anti-HGF, AMG 102 Vector Vector AMG 102
GTVCR-WQ463MR IVTScrip™ pT7-VEE-mRNA-Anti-IL23A, AMG-139 Vector Vector AMG-139
GTVCR-WQ1647MR IVTScrip™ pT7-VEE-mRNA-Anti-ICOS, JTX-2011 Vector Vector JTX-2011
GTVCR-WQ2495MR IVTScrip™ pT7-VEE-mRNA-Anti-stx2 A-subunit, Shigamabs® Vector Vector Shigamabs®
GTVCR-WQ206MR IVTScrip™ pSP6-VEE-mRNA-Anti-TNF, ABP 501 Vector Vector ABP 501
GTVCR-WQ311MR IVTScrip™ pT7-VEE-mRNA-Anti-CFD, AFD Anti-fD Vector Vector AFD Anti-fD
GTVCR-WQ1404MR IVTScrip™ pT7-VEE-mRNA-Anti-TACSTD2, aTROP2S7 Vector Vector aTROP2S7
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW